This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Hyung Gwan Lee: Innovator in Ginsenoside Glycosidase Protein
Introduction
Hyung Gwan Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of novel proteins that have potential health benefits.
Latest Patents
Hyung Gwan Lee holds 1 patent related to a novel ginsenoside glycosidase protein. This invention pertains to a protein derived from a specific genus, which has the ability to convert protopanaxadiol (PPD)-type saponins into highly active substances that can be absorbed by the body. The patent details the amino acid sequence of the protein, a nucleic acid sequence encoding the protein, and methods for producing the ginsenoside glycosidase through the culturing of transformants. Additionally, it includes a method for converting PPD-type major saponins into minor saponin forms using the protein.
Career Highlights
Hyung Gwan Lee is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work focuses on the innovative applications of biotechnology in health and wellness.
Collaborations
He has collaborated with notable coworkers, including Dong Shan An and Song Gun Kim, contributing to advancements in their respective fields.
Conclusion
Hyung Gwan Lee's innovative work in ginsenoside glycosidase protein exemplifies the potential of biotechnology to enhance health through scientific advancements. His contributions are paving the way for future research and applications in this vital area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile